Kyongbo Pharmaceutical Co Ltd (214390.KS) stock: key figures, P/E, revenue and dividend
Health Care · Pharmaceuticals · South Korea · ISIN KR7214390007
Kyongbo Pharmaceutical Co Ltd financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 238.56 bn KRW | 264.10 bn KRW |
| Gross profit | 89.27 bn KRW | 102.30 bn KRW |
| Operating income | 10.45 bn KRW | 3.52 bn KRW |
| EBIT | 9.19 bn KRW | 4.74 bn KRW |
| Net income | 4.64 bn KRW | 182.29 m KRW |
| Diluted EPS – continuing operations | 194.06 KRW | 7.63 KRW |
Full history since 2014, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Kyongbo Pharmaceutical Co Ltd
Kyongbo Pharmaceutical Co., Ltd manufactures and sells active pharmaceutical ingredients and finished drugs in South Korea and internationally. The company offers general, cephalosporins, and anti-cancer APIs; prescription drugs, including anesthetic, cardiovascular, digestive, and antibiotics; and OTC drugs. It also provides medical devices, including portable X-ray machine and ultrasonic diagnostic equipment; and extraporeal shockwave therapy and temperature control PROBE. In addition, the company is involved in CDMO business; and research and development of Clopidogrel cardiovascular drug, Imatinlb anticancer drug, Donepezil anti-psychotic drug, Entecavir for anti-virus and infectious disease, and Esomeprazole. It also exports its products. The company was formerly known as Kyongbo Chemical Co. Ltd. and changed its name to Kyongbo Pharmaceutical Co., Ltd in March 2002. Kyongbo Pharmaceutical Co., Ltd was founded in 1987 and is headquartered in Asan-si, South Korea.
More stocks
- Kencoa Aerospace Corporation (274090.KQ)
- Endeavor Bank (EDVR)
- Twinhead International Corp (2364.TW)
- Ruby Tech (8048.TWO)
- Hanshin Const (004960.KS)
- Apex Biotechnology Corp (1733.TW)
- Wheels Up Experience Inc. (UP)
- iCents Group Holdings Berhad (0366.KL)
- Stradvision, Inc. (475040.KQ)
- Oil Terminal C (OIL.RO)
- Shine-On BioMedical Co.,Ltd. (6926.TWO)
- SK D&D Co Ltd (210980.KS)
Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.